Table 1.
Clinicopathological data of the studied participant
| Characteristics | NSCLC Cases | Controls | Test of Sig | P |
|---|---|---|---|---|
| Age (years) | ||||
| Min.–Max | 30.0 – 75.0 | 34.0 – 78.0 | t = 1.671 | 0.101 |
| Mean ± SD | 59.04 ± 11.7 | 53.40 ± 12.16 | ||
| Sex | ||||
| Male | 23 (92%) | 23 (92%) | χ2 = 0.000 | FEp = 1.000 |
| Female | 2 (8%) | 2 (8%) | ||
| Smoking | ||||
| Non-smoker | 2 (8%) | 7 (28%) | χ2 = 3.388 | FEp = 0.138 |
| Smoker | 23 (92%) | 18 (72%) | ||
| Pathology | ||||
| SCC | 11 (44%) | |||
| Adenocarcinoma | 14 (56%) | |||
| Clinical stage at diagnosis: | ||||
| I | 2 (8%) | |||
| II | 3 (12%) | |||
| III | 10 (40%) | |||
| IV | 10 (40%) | |||
IQR Inter quartile range, SD Standard deviation, t Student t-test, χ2 Chi square test, FE Fisher Exact, pp value for comparing between the studied groups